Related Experiment Videos
Relationship between dialyser type and signs and symptoms
Summary
This study compared seven dialysers for hemodialysis symptoms. Duo-Flux and Filtral showed the lowest symptoms, while G120 M and G10-3N caused the most, despite patient and staff reporting differences.
Area of Science:
- Nephrology
- Biomaterials Science
- Clinical Research
Background:
- Hemodialysis requires effective dialyzers to manage waste products and fluid balance.
- Patient-reported symptoms during hemodialysis can significantly impact quality of life.
- Dialyzer biocompatibility is crucial for minimizing adverse events and improving patient tolerance.
Purpose of the Study:
- To compare the intradialytic symptoms and signs associated with seven different dialyzers.
- To evaluate the biocompatibility of various dialyzers based on patient and staff reporting.
- To identify factors influencing symptom perception and reporting in hemodialysis patients.
Main Methods:
- A crossover study involving 37 patients across five centers in four countries.
- Standardized collection of clinical and technical data, including symptoms and dialyzer performance.
- Patient questionnaires and staff observations were used to assess intradialytic symptoms and signs.
Main Results:
- Dialyzers Duo-Flux and Filtral demonstrated the lowest incidence of bioincompatibility symptoms.
- Dialyzers G120 M and G10-3N were associated with the highest reported symptoms by staff and patients.
- Patient and staff perceptions of symptoms varied significantly, influenced by cultural and hemodynamic factors.
- Two hypersensitivity reactions occurred with cuprammonium cellulose dialyzers, linked to ethylene oxide-human serum albumin antibodies.
Conclusions:
- A hierarchy of dialyzer-related symptoms and signs was identified, correlating with laboratory biocompatibility findings.
- Individual perceptions, staff reactions, and recording efficiency complicate symptom reporting.
- Future studies should account for these variables when assessing dialyzer biocompatibility and structure-symptom relationships.